达拉图穆马
不良事件报告系统
医学
药物警戒
不利影响
肿瘤科
内科学
多发性骨髓瘤
硼替佐米
作者
Junlin Wu,Han-Biao Wu,Lili Chen,Haiping Liang,Guoning Huang,Sensen Yang,Bishan Chen,Yoshihiro Noguchi,Yonggang Shen
标识
DOI：10.1080/14740338.2023.2296966
摘要
Background Daratumumab is widely used in multiple myeloma (MM) and light chain amyloidosis (AL amyloidosis). The purpose of this study was to identify adverse event (AE) signals for daratumumab through the FDA Adverse Event Reporting System (FAERS) database to assess its safety in a large sample of people.
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
加菲丰丰
有人
shinysparrow
寻道图强
可口可乐了
乐乐乐乐乐乐
景辣条
充电宝
精明元霜
mmyhn
sirius
AireenBeryl531
星辰大海
kento
Lucas
morena
spark810
丘比特
浅尝离白
皖公网安备34019202002308
